April 16, 2020

FDA updates actions taken in response to COVID-19

Editor's Note

Among the actions announced April 15 by the Food & Drug Administration (FDA) in response to the COVID-19 pandemic are:

  • Issuance of two new emergency use authorizations (EUAs) for serology tests, to detect for presence of coronavirus antibodies, to Ortho-Clinical Diagnostics, Inc, and Chembio Diagnostic systems, Inc.
  • Issuance of an EUA for the use of Stryker Instrument’s Sterizone VP4 Sterilizer N95 Respirator Decontamination Cycle for decontaminating N95 respirators.
  • Issuance of a “Guidance on digital health devices for treating psychiatric disorders” in an effort to expand the availability of these devices while reducing user and healthcare provider contact.


Join our community

Learn More
Video Spotlight
Live chat by BoldChat